SIP
FOLD

Stoneridge Investment Partners’s Amicus Therapeutics FOLD Stock Holding History

Stoneridge Investment Partners’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-48,064
Closed -$161K – 257
2014
Q2 		$161K Buy
48,064
+23,625
+97% +$55.5K 0.02% 216
2014
Q1 		$51K Sell
24,439
-700
-3% -$1.75K 0.01% 204
2013
Q4 		$59K Buy
25,139
+400
+2% +$878 0.01% 203
2013
Q3 		$57K Buy
24,739
+4,200
+20% +$10.5K 0.01% 205
2013
Q2 		$48K Buy
+20,539
New +$63.1K 0.01% 201

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Stoneridge Investment Partners's FOLD Position: Q3 2014 in Review

Stoneridge Investment Partners sold out of Amicus Therapeutics (FOLD) in Q3 2014, closing a stake of 48,064 shares — an estimated $161K sold.

Stoneridge Investment Partners first reported a position in FOLD in Q2 2013 and held it in 5 quarters. The position peaked at $161K in Q2 2014. 95 funds tracked by Wall St. Rank hold FOLD as of Q3 2014.

  • Stoneridge Investment Partners reported no remaining Amicus Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Stoneridge Investment Partners sold 48,064 Amicus Therapeutics shares in Q3 2014, an estimated $161K.
  • Stoneridge Investment Partners first reported a position in Amicus Therapeutics in Q2 2013 and held it in 5 quarters.
  • Stoneridge Investment Partners's Amicus Therapeutics position peaked at $161K in Q2 2014.
  • 95 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2014.

Based on Stoneridge Investment Partners's 13F filing for Q3 2014, filed 22 Oct 2014.